ROBERT S ELLIN
CIK 1071292 · CEO & Chairman · last filed 2025-07-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$154.47M
Companies
9
Total Filings
189
Lifetime Open-Market Net
-$16.83M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LVO | CEO & Chairman | 23,969,618 | $6.26 | $150.05M | $498.7K | 22 | 2025-07-17 |
| PODC | Executive Chairman | 1,034,282 | $4.27 | $4.42M | $127.8K | 8 | 2024-12-02 |
| LiveOne, Inc. (LIVX) Delisted | CEO & Chairman | 18,557,693 | $3.07 | $56.97M | $1.54M | 91 | 2021-09-14 |
| Ernexa Therapeutics Inc. (NTN) Delisted | 10%+ Owner | 16,615 | $2.70 | $44.9K | -$1.72M | 19 | 2020-08-17 |
| Digital Turbine, Inc. (MNDL) Delisted | 10%+ Owner | 4,077,461 | — | — | -$14.62M | 3 | 2014-03-25 |
| Protagenic Therapeutics, Inc.\new (ATRN) Delisted | Director | — | — | — | $0 | 1 | 2010-09-30 |
| COMMAND SECURITY CORP (MOC) Delisted | 10%+ Owner | 1,194,040 | — | — | $0 | 1 | 2010-01-14 |
| Forward Industries, Inc. (FORD) Delisted | 10%+ Owner | 657,791 | $9.48 | $6.24M | -$2.66M | 3 | 2008-12-01 |
| Protagenic Therapeutics, Inc.\new (NWMO) Delisted | 10%+ Owner | 2,178,170 | — | — | $0 | 1 | 2008-02-07 |
Recent Filings · Page 9 of 19
189 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-12-04 | Ernexa Therapeutics Inc. (NTN) Delisted | Buy (P) | +100 | $350 | EDGAR |
| 2019-10-30 | Ernexa Therapeutics Inc. (NTN) Delisted | Buy (P) | +881 | $2.8K | EDGAR |
| 2019-10-28 | Ernexa Therapeutics Inc. (NTN) Delisted | Buy (P) | +302 | $934 | EDGAR |
| 2019-10-24 | Ernexa Therapeutics Inc. (NTN) Delisted | Buy (P) | +4,801 | $13.3K | EDGAR |
| 2019-10-16 | Ernexa Therapeutics Inc. (NTN) Delisted | Buy (P) | +300 | $1.1K | EDGAR |
| 2019-10-09 | Ernexa Therapeutics Inc. (NTN) Delisted | Buy (P) | +100 | $367 | EDGAR |
| 2019-10-07 | Ernexa Therapeutics Inc. (NTN) Delisted | Buy (P) | +393 | $1.2K | EDGAR |
| 2019-10-02 | Ernexa Therapeutics Inc. (NTN) Delisted | Buy (P) | +300 | $1.1K | EDGAR |
| 2019-09-30 | Ernexa Therapeutics Inc. (NTN) Delisted | Buy (P) | +4,831 | $14.2K | EDGAR |
| 2019-09-26 | Ernexa Therapeutics Inc. (NTN) Delisted | Buy (P) | +28,700 | $71.9K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.